000 | 01496 a2200361 4500 | ||
---|---|---|---|
005 | 20250513183214.0 | ||
264 | 0 | _c19990614 | |
008 | 199906s 0 0 eng d | ||
022 | _a0892-6638 | ||
024 | 7 |
_a10.1096/fasebj.13.9.965 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKeaney, J F | |
245 | 0 | 0 |
_aVitamin E and vascular homeostasis: implications for atherosclerosis. _h[electronic resource] |
260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cJun 1999 |
||
300 |
_a965-75 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aAntioxidants _xmetabolism |
650 | 0 | 4 |
_aArteriosclerosis _xdrug therapy |
650 | 0 | 4 |
_aBlood Cells _xdrug effects |
650 | 0 | 4 |
_aBlood Vessels _xphysiology |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aHomeostasis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
650 | 0 | 4 |
_aVitamin E _xmetabolism |
700 | 1 | _aSimon, D I | |
700 | 1 | _aFreedman, J E | |
773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 13 _gno. 9 _gp. 965-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1096/fasebj.13.9.965 _zAvailable from publisher's website |
999 |
_c10295667 _d10295667 |